Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

61247 Press Releases
DateTitleCompany
01 Aug 11 NanoViricides Expands On Prior HIVCide Effectiveness Release NanoViricides Inc.,
Published by
Business Wire
01 Aug 11 CytRx’s INNO-206 in Combination Therapy Induces Complete Remissions in Aggressively Growing Ovarian Cancer Tumor Model CytRx Corporation,
Published by
Business Wire
01 Aug 11 RainDance MethylSeq™ Solution Powers Two New Epigenetic Studies Focused on Cell Differentiation and Cancer Progression RainDance Technologies Inc.,
Published by
Business Wire
01 Aug 11 ARIAD Announces That Its Partner, Merck, Has Submitted for Approval of Ridaforolimus, an Investigational mTOR Inhibitor, in the European Union ARIAD Pharmaceuticals Inc.,
Published by
Business Wire
01 Aug 11 SeraCare Life Sciences Announces Decision to Explore Strategic Alternatives, Including Possible Sale of the Company SeraCare Life Sciences Inc.,
Published by
Business Wire
01 Aug 11 Cubist Announces First Patient Dosed in Pivotal Global Phase 3 Trial of CXA-201 for Complicated Urinary Tract Infections Cubist Pharmaceuticals Inc.,
Published by
Business Wire
01 Aug 11 Fera Pharmaceuticals Launches Four Ophthalmic Ointments Fera Pharmaceuticals,
Published by
Business Wire
01 Aug 11 Covidien Receives FDA Approval for Morphine Sulfate Oral Solution Covidien,
Published by
Business Wire
01 Aug 11 SENOMYX, INC. SECOND QUARTER EARNINGS CONFERENCE CALL SCHEDULED FOR AUGUST 5, 2011 Senomyx Inc.,
Published by
Business Wire
01 Aug 11 PathoGenetiX Inc. Completes First Close of Series B Financing to Advance Rapid Pathogen Identification System PathoGenetiX Inc.,
Published by
Business Wire
01 Aug 11 Femta Pharmaceuticals Announces IND Filing of FM101, a Novel Monoclonal Antibody Targeting IL-6 with Potent Anti-Inflammatory Activity Femta Pharmaceuticals,
Published by
Business Wire
01 Aug 11 First Clinical Cases at The University of Kansas Hospital utilizing the Advanced Perfusor® Syringe Pump for Adenocaine® Hiberplegia™ Hibernation Therapeutics USA LLC,
Published by
Business Wire
01 Aug 11 New Article Exposes Corruption of Science in America ERELEASES,
Published by
PR Newswire
01 Aug 11 PDI Announces John L. Parsons Jr. to Lead New Product Commercialization Enterprise, Interpace BioPharma, LLC WEST MILL MARKETING RESEARCH & COMMUNICATIONS,
Published by
PR Newswire
01 Aug 11 PDI Announces $55 Million Agreement to Market Rx Product Through 2013 for Treatment of Knee Pain WEST MILL MARKETING RESEARCH & COMMUNICATIONS,
Published by
PR Newswire
01 Aug 11 Global Vaccines Market Boost From Prevnar13: companiesandmarkets.com Companies & Markets,
Published by
Business Wire
01 Aug 11 China Jo-Jo Drugstores, Inc. Appoints New Chief Financial Officer China Jo-Jo Drugstores Inc.,
Published by
Business Wire
01 Aug 11 Acorda Therapeutics Reports Second Quarter 2011 Financial Results Acorda Therapeutics Inc.,
Published by
Business Wire
01 Aug 11 Affymetrix To Release Axiom Array Plates Optimized for NIH-funded Genotyping Study of 100,000 People Affymetrix Inc.,
Published by
Business Wire
01 Aug 11 Bendavia Presented at 2011 American Heart Association’s Cardiovascular Scientific Sessions Stealth Peptides Inc.,
Published by
Business Wire
01 Aug 11 ZIOPHARM Reports Second Quarter Financial Results and Highlights ZIOPHARM Oncology,
Published by
Business Wire
01 Aug 11 OPEN Health launches OPEN Plan: Global Healthcare market research and brand planning consultancy OPEN Health
01 Aug 11 Insulin- Western Europe REPORTLINKER.COM,
Published by
PR Newswire
01 Aug 11 Columbus Says “NOT ME” to Diabetes; UnitedHealth Group Diabetes Prevention and Control Alliance Programs Now Available to Municipal Workers UnitedHealth Group,
Published by
Business Wire
01 Aug 11 Research and Markets: Pharmaceutical Pricing, Reimbursement, and Market Access in Poland, Romania and Ukraine Research and Markets,
Published by
Business Wire
01 Aug 11 The Market for Biopharmaceuticals was Worth USD 101 Billion in 2010 IMARC Group
30 Jul 11 U.S. Food and Drug Administration Approves Subcutaneous Formulation of ORENCIA® (abatacept), a Proven Non-Anti-TNF Biologic for Adults with Moderate to Severe Rheumatoid Arthritis Bristol-Myers Squibb,
Published by
Business Wire
30 Jul 11 Dance 4 Your Life! Gets Americans Moving for National Dance Day Dance 4 Your Life!,
Published by
Business Wire
30 Jul 11 Pfizer Provides U.S. Regulatory Update on Prevnar 13® for Use in Adults 50 Years and Older Pfizer Inc,
Published by
Business Wire
30 Jul 11 Research and Markets: Aids - Related Lymphoma - Pipeline Review, Q3 2011 Is Built Using Data and Information Sourced from Proprietary Databases Research and Markets,
Published by
Business Wire
Advertising